Morgan Stanley Anika Therapeutics, Inc. Transaction History
Morgan Stanley
- $1.49 Trillion
- Q2 2025
A detailed history of Morgan Stanley transactions in Anika Therapeutics, Inc. stock. As of the latest transaction made, Morgan Stanley holds 108,382 shares of ANIK stock, worth $945,091. This represents 0.0% of its overall portfolio holdings.
Number of Shares
108,382
Previous 124,836
13.18%
Holding current value
$945,091
Previous $1.88 Million
38.91%
% of portfolio
0.0%
Previous 0.0%
Shares
24 transactions
Others Institutions Holding ANIK
# of Institutions
105Shares Held
11.4MCall Options Held
0Put Options Held
0-
Trigran Investments, Inc.2.04MShares$17.8 Million0.91% of portfolio
-
Black Rock Inc. New York, NY1.61MShares$14 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA779KShares$6.8 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX623KShares$5.43 Million0.0% of portfolio
-
Opaleye Management Inc. Boston, MA589KShares$5.13 Million1.49% of portfolio
About Anika Therapeutics, Inc.
- Ticker ANIK
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 14,599,900
- Market Cap $127M
- Description
- Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactur...